PATENT CLAIM ANALYSIS

Application Number: 15756469
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["424", "623000"]

Abstract:
The present invention includes methods of treating patients with acute myeloid leukemia across a range of genetic subtypes with DHODH inhibitors, such as 6-fluoro-2-(2′-fluoro-[1,1′-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid).

Claim (Index 6):
The method according to  claim 1 , wherein the subject has been treated or is being treated for a hematological cancer characterized by differentiation arrest.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14733498', '15277857', '12672715', '13762238', '14909713']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6359612878473969
- 35 USC 102 Novelty (BERT): 0.5156612425081119
- Combined Prediction Score: 0.6239312833134685
- Mean Citation Score: 257.720306
- Max Citation Score: 285.75818
- Similarity Product: 197.5077813371825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test